Early Engagement with HTA Bodies
In-depth guide to successful early HTA engagement.
Certara2021年5月10日
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Watch this presentation to learn • Overview of the SNDS and the key working practices…
Certara2021年5月7日
Maximizing Oligonucleotide Therapeutic Development: How They Work
This is the first of three blog posts discussing best practices for developing oligonucleotides. Interest…
Certara2021年5月7日
The Wizard of Oligos: There’s no place like having a successful drug development program!
Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…
Certara2021年4月30日
The Promises and Pitfalls of Gene Therapy for Rare Diseases
The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have…
Certara2021年4月29日
Certara (CERT) – Accelerating Medicines with Biosimulation
As seen on CNBC** Certara is the global leader in biosimulation, a powerful and proven…
Certara2021年4月27日
